The PD-1/B7-H1 Pathway Modulates the Natural Killer Cells versus Mouse Glioma Stem Cells-Reference-Cited by-同舟云学术

The PD-1/B7-H1 Pathway Modulates the Natural Killer Cells versus Mouse Glioma Stem Cells

Published:2015-08-12 Issue:8 Volume:10 Page:e0134715
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Huang Bo Yuan,Zhan Yi Ping,Zong Wen Jing,Yu Chun Jiang,Li Jun Fa,Qu Yan Ming,Han Song

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. The 2007 WHO classifiation of tumours of the central nervous system;DN Louis;Acta Neuropathol,2007

2. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;R1 Stupp;Lancet Oncol,2009

3. Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production;J Baker;Blood,2001

4. A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immuno-deficiency;PH Lu;J Immunol,1994

5. Role played by the programmed death-1-programmed death ligand pathway during innate immunity against Mycobacterium tuberculosis;IB Alvarez;J Infect Dis,2010

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of overall survival-EMT-immune cell infiltration genes predict the prognosis of glioma;Non-coding RNA Research;2024-06

2. Pentraxin 3: A Main Driver of Inflammation and Immune System Dysfunction in the Tumor Microenvironment of Glioblastoma;Cancers;2024-04-24

3. Constructing a Nucleotide Metabolism Related Prognostic Model Based on Bioinformatics to Explore the Potential Molecular Mechanisms of Glioblastoma;2024-04-18

4. The Development of Immunotherapy for the Treatment of Recurrent Glioblastoma;Cancers;2023-08-29

5. Cancer stem cells in brain tumors: From origin to clinical implications;MedComm;2023-08